12 Weeks' aerobic and resistance training without dietary intervention did not influence oxidative stress but aerobic training decreased atherogenic index in middle-aged men with impaired glucose regulation

Food and Chemical Toxicology

Volumn 61, Issue , 2013, Pages 127-135

  Venojärvi, Mika ^a   Korkmaz, Ayhan ^a   Wasenius, Niko ^b   Manderoos, Sirpa ^b,c   Heinonen, Olli J ^d   Lindholm, Harri ^e   Aunola, Sirkka ^c   Eriksson, Johan G ^b,f,g   Atalay, Mustafa ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d UNIVERSITY OF TURKU   (Finland)

^e FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^f FOLKHÄLSAN RESEARCH CENTER   (Finland)

^g VAASA CENTRAL HOSPITAL   (Finland)

Author keywords

Atherogenic index; Impaired glucose regulation; Metabolic syndrome; Nordic walking; Oxidative stress; Resistance training

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER; CYTOKINE; OSTEOPONTIN; OSTEOPROTEGERIN;

ADULT; AEROBIC EXERCISE; AGE; AGED; ARTICLE; ATHEROGENIC INDEX; BODY MASS; CONTROLLED STUDY; EXERCISE INTENSITY; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; MEDICAL PARAMETERS; METABOLIC SYNDROME X; NORDIC WALKING; OBESITY; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; RESISTANCE TRAINING; TREATMENT DURATION; WEIGHT REDUCTION;

AIP; ATHEROGENIC INDEX; ATHEROGENIC INDEX OF PLASMA; BMI; BODY MASS INDEX; C; CAD; CARDIOVASCULAR DISEASE; CONTROL GROUP; CORONARY ARTERY DISEASE; CVD; HDL; HIGH DENSITY LIPOPROTEIN; HMW; HUMAN HIGH MOLECULAR WEIGHT; IDF; IGR; IGT; IMPAIRED GLUCOSE REGULATION; IMPAIRED GLUCOSE TOLERANCE; INTERNATIONAL DIABETES FEDERATION; LDL; LIPID HYDROPEROXIDES; LOW DENSITY LIPOPROTEIN; LPO; MALONDIALDEHYDE; MDA; MET; METABOLIC EQUIVALENT OF TASK; METABOLIC SYNDROME; METS; NORDIC WALKING; NORDIC WALKING GROUP; NW; OB; OBESE GROUP; OGTT; OPG; OPN; ORAC; ORAL GLUCOSE TOLERANCE TEST; OSTEOPONTIN; OSTEOPROTEGERIN; OVERWEIGHT GROUP; OW; OX-LDL; OXIDATIVE STRESS; OXIDIZED LDL; OXYGEN RADICAL ABSORBANCE CAPACITY; REACTIVE OXYGEN SPECIES; RESISTANCE TRAINING; RESISTANCE TRAINING GROUP; ROS; RT; SD; SE; STANDARD DEVIATIONS; STANDARD ERRORS; TGS; TRIGLYCERIDES;

ADULT; AGED; ANTIOXIDANTS; ATHEROSCLEROSIS; BODY MASS INDEX; DIET; EXERCISE; GLUCOSE; HUMANS; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; OSTEOPONTIN; OSTEOPROTEGERIN; OVERWEIGHT; OXIDATIVE STRESS; RESISTANCE TRAINING; WALKING;

EID: 84888835089     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2013.04.015     Document Type: Article

References (73)

1. Aicher B.O., Haser E.K., Freeman L.A., Carnie A.V., Stonik J.A., Wang X., Remaley A.T., Kato G.J., Cannon R.O. Diet-induced weight loss in overweight or obese women and changes in high-density lipoprotein levels and function. Obesity (Silver Spring) 2012, 20:2057-2062.
2. Armutcu F., Ataymen M., Atmaca H., Gurel A. Oxidative stress markers, C-reactive protein and heat shock protein 70 levels in subjects with metabolic syndrome. Clin. Chem. Lab. Med. 2008, 46:785-790.
3. Ashley D.T., O'Sullivan E.P., Davenport C., Devlin N., Crowley R.K., McCaffrey N., Moyna N.M., Smith D., O'Gorman D.J. Similar to adiponectin, serum levels of osteoprotegerin are associated with obesity in healthy subjects. Metabolism 2011, 60:994-1000.
4. Aso Y., Yamamoto R., Wakabayashi S., Uchida T., Takayanagi K., Takebayashi K., Okuno T., Inoue T., Node K., Tobe T., Inukai T., Nakano Y. Comparison of serum high-molecular weight (HMW) adiponectin with total adiponectin concentrations in type 2 diabetic patients with coronary artery disease using a novel enzyme-linked immunosorbent assay to detect HMW adiponectin. Diabetes 2006, 55:1954-1960.
5. Atalay M., Laaksonen D.E. Diabetes, oxidative stress and physical exercise. J. Sports Sci. Med. 2002, 1:1-14.
6. Bae J.H., Bassenge E., Kim K.B., Kim Y.N., Kim K.S., Lee H.J., Moon K.C., Lee M.S., Park K.Y., Schwemmer M. Postprandial hypertriglyceridemia impairs endothelial function by enhanced oxidant stress. Atherosclerosis 2001, 155:517-523.
7. Bahadoran Z., Mirmiran P., Hosseinpanah F., Rajab A., Asghari G., Azizi F. Broccoli sprouts powder could improve serum triglyceride and oxidized LDL/LDL-cholesterol ratio in type 2 diabetic patients: a randomized double-blind placebo-controlled clinical trial. Diabetes Res. Clin. Pract. 2012, 96:348-354.
8. Bateman L.A., Slentz C.A., Willis L.H., Shields A.T., Piner L.W., Bales C.W., Houmard J.A., Kraus W.E. Comparison of aerobic versus resistance exercise training effects on metabolic syndrome (from the Studies of a Targeted Risk Reduction Intervention Through Defined Exercise - STRRIDE-AT/RT). Am. J. Cardiol. 2011, 108:838-844.
9. Bertola A., Deveaux V., Bonnafous S., Rousseau D., Anty R., Wakkach A., Dahman M., Tordjman J., Clément K., McQuaid S.E., Frayn K.N., Huet P.M., Gugenheim J., Lotersztajn S., Le Marchand-Brustel Y., Tran A., Gual P. Elevated expression of osteopontin may be related to adipose tissue macrophage accumulation and liver steatosis in morbid obesity. Diabetes 2009, 58:125-133.
10. Breusing N., Grune T., Andrisic L., Atalay M., Bartosz G., Biasi F., Borovic S., Bravo L., Casals I., Casillas R., Dinischiotu A., Drzewinska J., Faber H., Fauzi N.M., Galecka A., Gambini J., Gradinaru D., Kokkola T., Lojek A., Łuczaj W., Margina D., Mascia C., Mateos R., Meinitzer A., Mitjavila M.T., Mrakovcic L., Munteanu M.C., Podborska M., Poli G., Sicinska P., Skrzydlewska E., Vina J., Wiswedel I., Zarkovic N., Zelzer S., Spickett C.M. Results of an interlaboratory validation of methods of lipid peroxidation measurements. Free Radical Res. 2010, 44:1203-1215.
11. Brinton E.A., Eisenberg S., Breslow J.L. A low-fat diet decreases high density lipoprotein (HDL) cholesterol levels by decreasing HDL apolipoprotein transport rates. J. Clin. Invest. 1990, 85:144-151.
12. Cakir-Atabek H., Demir S., PinarbaŞili R.D., Gündüz N. Effects of different resistance training intensity on indices of oxidative stress. J. Strength Cond. Res. 2010, 24:2491-2497.
13. Casella-Filho A., Chagas A.C., Maranhão R.C., Trombetta I.C., Cesena F.H., Silva V.M., Tanus-Santos J.E., Negrão C.E., da Luz P.L. Effect of exercise training on plasma levels and functional properties of high-density lipoprotein cholesterol in the metabolic syndrome. Am. J. Cardiol. 2011, 107:1168-1172.
14. Chapman M.J., Guérin M., Bruckert E. Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches. Eur. Heart J. 1998, 19:24-30.
15. Dandona P., Aljada A., Chaudhuri A., Mohanty P., Garg R. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 2005, 111:1448-1454.
16. Davenport C., Kenny H., Ashley D.T., O'Sullivan E.P., Smith D., O'Gorman D.J. The effect of exercise on osteoprotegerin and TNF-related apoptosis-inducing ligand in obese patients. Eur. J. Clin. Invest. 2012, 42:1173-1179.
17. Després J.P., Lemieux I., Bergeron J., Pibarot P., Mathieu P., Larose E., Rodés-Cabau J., Bertrand O.F., Poirier P. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler. Thromb. Vasc. Biol. 2008, 28:1039-1049.
18. Dobiásová M., Frohlich J. The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL)). Clin. Biochem. 2001, 34:583-588.
19. Dobiásová M., Frohlich J., Sedová M., Cheung M.C., Brown B.G. Cholesterol esterification and atherogenic index of plasma correlate with lipoprotein size and findings on coronary angiography. J. Lipid Res. 2011, 52:566-571.
20. Ervin R.B. Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003-2006. Natl. Health Stat. Rep. 2009, 5:1-7.
21. Faller J., Fox I.H. Ethanol-induced hyperuricemia: evidence for increased urate production by activation of adenine nucleotide turnover. N. Engl. J. Med. 1982, 307:1598-1602.
22. Figard-Fabre H., Fabre N., Leonardi A., Schena F. Efficacy of Nordic walking in obesity management. Int. J. Sports Med. 2011, 32:407-414.
23. Ford E.S. Prevalence of the metabolic syndrome defined by the international diabetes federation among adults in the US. Diabetes Care 2005, 28:2745-2749.
24. Ford E.S., Giles W.H., Mokdad A.H. Increasing prevalence of the metabolic syndrome among US adults. Diabetes Care 2004, 27:2444-2449.
25. Georgiadou P., Iliodromitis E.K., Varounis C., Mavroidis M., Kolokathis F., Andreadou I., Psarras S., Capetanaki Y., Boudoulas H., Kremastinos D.T. Relationship between plasma osteopontin and oxidative stress in patients with coronary artery disease. Exp. Opin. Ther. Targets 2008, 12:917-920.
26. Gómez-Ambrosi J., Catalán V., Ramírez B., Rodríguez A., Colina I., Silva C., Rotellar F., Mugueta C., Gil M.J., Cienfuegos J.A., Salvador J., Frühbeck G. Plasma osteopontin levels and expression in adipose tissue are increased in obesity. J. Clin. Endocrinol. Metab. 2007, 92:3719-3727.
27. Gordon L.A., Morrison E.Y., McGrowder D.A., Young R., Fraser Y.T., Zamora E.M., Alexander-Lindo R.L., Irving R.R. Effect of exercise therapy on lipid profile and oxidative stress indicators in patients with type 2 diabetes. BMC Complement Altern. Med. 2008, 13(8):21.
28. Grundy S.M. Pre-diabetes, metabolic syndrome, and cardiovascular risk. J. Am. Coll. Cardiol. 2012, 59:635-643.
29. Guerrero-Romero F., Rodríguez-Morán M. Hypomagnesemia, oxidative stress, inflammation, and metabolic syndrome. Diabetes Metab. Res. Rev. 2006, 22:471-476.
30. Gürsoy G., Alagöz S., Acar Y., Demirbas B., Çetiner H., Kiliç Z. Osteopontin a new probable marker for atherosclerosis in obese women?. Clin. Rev. Opin. 2010, 2(3):35-40.
31. Hagner W., Hagner-Derengowska M., Wiacek M., Zubrzycki I.Z. Changes in level of VO2max, blood lipids, and waist circumference in the response to moderate endurance training as a function of ovarian aging. Menopause 2009, 16:1009-1013.
32. Hara K., Horikoshi M., Yamauchi T., Yago H., Miyazaki O., Ebinuma H., Imai Y., Nagai R., Kadowaki T. Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care 2006, 29:1357-1362.
33. Hollman G., Kristenson M. The prevalence of the metabolic syndrome and its risk factors in a middle-aged Swedish population-mainly a function of overweight?. Eur. J. Cardiovasc. Nurs. 2008, 7:21-26.
34. Hopps E., Noto D., Caimi G., Averna M.R. A novel component of the metabolic syndrome: the oxidative stress. Nutr. Metab. Cardiovasc. Dis. 2010, 20:72-77.
35. Huang P., Li S., Shao M., Qi Q., Zhao F., You J., Mao T., Li W., Yan Z., Liu Y. Calorie restriction and endurance exercise share potent anti-inflammatory function in adipose tissues in ameliorating diet-induced obesity and insulin resistance in mice. Nutr. Metab. (Lond) 2010, 7:59.
36. Hutcheson R., Rocic P. The metabolic syndrome, oxidative stress, environment, and cardiovascular disease: the great exploration. Exp. Diabetes Res. 2012, 2012:271028.
37. Jones N.L. Clinical Exercise Testing 1998, WB Saunders Co., Philadelphia, Pa. second ed.
38. Katzmarzyk P.T., Janssen I. The economic costs associated with physical inactivity and obesity in Canada: an update. Can. J. Appl. Physiol. 2004, 29:90-115. (revue Canadienne de Physiologie Appliqué).
39. Kinnunen S., Hyyppä S., Lehmuskero A., Oksala N., Mäenpää P., Hänninen O., Atalay M. Oxygen radical absorbance capacity (ORAC) and exercise-induced oxidative stress in trotters. Eur. J. Appl. Physiol. 2005, 95:550-556.
40. Kinnunen S., Oksala N.K.J., Hyyppä S., Sen C.K., Radak Z., Szabó B., Jakus J., Atalay M. α-Lipoic acid modulates thiol antioxidant defences and decreases exercise-induced oxidative stress in standardbred trotters. Free Radical Res. 2009, 43:697-705.
41. Kotani K., Tsuzaki K., Sakane N., Taniguchi N. The correlation between small dense LDL and reactive oxygen metabolites in a physical activity intervention in hyperlipidemic subjects. J. Clin. Med. Res. 2012, 4:161-166.
42. Kraus W.E., Houmard J.A., Duscha B.D., Knetzger K.J., Wharton M.B., McCartney J.S., Bales C.W., Henes S., Samsa G.P., Otvos J.D., Kulkarni K.R., Slentz C.A. Effects of the amount and intensity of exercise on plasma lipoproteins. N. Engl. J. Med. 2002, 347:1483-1492.
43. Laaksonen D.E., Lakka H.M., Salonen J.T., Niskanen L.K., Rauramaa R., Lakka T.A. Low levels of leisure-time physical activity and cardiorespiratory fitness predict development of the metabolic syndrome. Diabetes Care 2002, 25:1612-1618.
44. Laaksonen D.E., Niskanen L., Lakka H.M., Lakka T.A., Uusitupa M. Epidemiology and treatment of the metabolic syndrome. Ann. Med. 2004, 36:332-346.
45. Lazarevic G., Antic S., Cvetkovic T., Djordjevic V., Vlahovic P., Stefanovic V. Effects of regular exercise on cardiovascular risk factors profile and oxidative stress in obese type 2 diabetic patients in regard to SCORE risk. Acta Cardiol. 2008, 63:485-491.
46. Lim S., Jang H.C., Park K.S., Cho S.I., Lee M.G., Joung H., Mozumdar A., Liguori G. Changes in metabolic syndrome in American and Korean youth, 1997-2008. Pediatrics 2013, 131:e214-e222.
47. Lippi G., Schena F., Salvagno G.L., Montagnana M., Ballestrieri F., Guidi G.C. Comparison of the lipid profile and lipoprotein(a) between sedentary and highly trained subjects. Clin. Chem. Lab. Med. 2006, 44:322-326.
48. McDonagh M.J., Davies C.T. Adaptive response of mammalian skeletal muscle to exercise with high loads. Eur. J. Appl. Physiol. Occup. Physiol. 1984, 52:139-155.
49. McNeilly A.M., McClean C., Murphy M., McEneny J., Trinick T., Burke G., Duly E., McLaughlin J., Davison G. Exercise training and impaired glucose tolerance in obese humans. J. Sports Sci. 2012, 30:725-732.
50. Montagnana M., Lippi G., Danese E., Guidi GC. The role of osteoprotegerin in cardiovascular disease. Ann. Med. 2012, (Epub ahead of print).
51. Nakano Y., Tajima S., Yoshimi A., Akiyama H., Tsushima M., Tanioka T., Negoro T., Tomita M., Tobe T. A novel enzyme-linked immunosorbent assay specific for high-molecular-weight adiponectin. J. Lipid Res. 2006, 47:1572-1582.
52. Oksala N., Paimela H., Alhava E., Atalay M. Heat shock preconditioning induces protein carbonylation and alters antioxidant protection in superficially injured guinea pig gastric mucosa in vitro. Dig. Dis. Sci. 2007, 52:1897-1905.
53. Onat A., Can G., Kaya H., Hergenç G. "Atherogenic index of plasma" (log 10 triglyceride/high-density lipoprotein-cholesterol) predicts high blood pressure, diabetes, and vascular events. J. Clin. Lipidol. 2010, 4:89-98.
54. Ostergård T., Nyholm B., Hansen T.K., Rasmussen L.M., Ingerslev J., Sørensen K.E., Bøtker H.E., Saltin B., Schmitz O. Endothelial function and biochemical vascular markers in first-degree relatives of type 2 diabetic patients: the effect of exercise training. Metabolism 2006, 55:1508-1515.
55. Otani H. Oxidative stress as pathogenesis of cardiovascular risk associated with metabolic syndrome. Antioxid. Redox Signal. 2011, 15:1911-1926.
56. Pajvani U.B., Du X., Combs T.P., Berg A.H., Rajala M.W., Schulthess T., Engel J., Brownlee M., Scherer P.E. Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications for metabolic regulation and bioactivity. J. Biol. Chem. 2003, 278:9073-9085.
57. Podrez E.A. Anti-oxidant properties of high-density lipoprotein and atherosclerosis. Clin. Exp. Pharmacol. Physiol. 2010, 37:719-725.
58. Rector R.S., Warner S.O., Liu Y., Hinton P.S., Sun G.Y., Cox R.H., Stump C.S., Laughlin M.H., Dellsperger K.C., Thomas T.R. Exercise and diet induced weight loss improves measures of oxidative stress and insulin sensitivity in adults with characteristics of the metabolic syndrome. Am. J. Physiol. Endocrinol. Metab. 2007, 293:500-506.
59. Sankhla M., Sharma T.K., Mathur K., Rathor J.S., Butolia V., Gadhok A.K., Vardey S.K., Sinha M., Kaushik G.G. Relationship of oxidative stress with obesity and its role in obesity induced metabolic syndrome. Clin. Lab. 2012, 58:385-392.
60. Seino Y., Hirose H., Saito I., Itoh H. High molecular weight multimer form of adiponectin as a useful marker to evaluate insulin resistance and metabolic syndrome in Japanese men. Metabolism 2007, 56:1493-1499.
61. Sharma N., Baliarsingh S. High fasting serum glucose in non-diabetic subjects ≥45 years is an indicator of future cardiovascular events as it is positively associated with atherogenic index of plasma. Arch. Physiol. Biochem. 2012, 118:43-46.
62. Soška V., Jarkovský J., Ravčuková B., Tichý L., Fajkusová L., Freiberger T. The logarithm of the triglyceride/HDL-cholesterol ratio is related to the history of cardiovascular disease in patients with familial hypercholesterolemia. Clin. Biochem. 2012, 45:96-100.
63. Tousoulis D., Siasos G., Maniatis K., Oikonomou E., Kioufis S., Zaromitidou M., Paraskevopoulos T., Michalea S., Kollia C., Miliou A., Kokkou E., Papavassiliou A.G., Stefanadis C. Serum osteoprotegerin and osteopontin levels are associated with arterial stiffness and the presence and severity of coronary artery disease. Int J Cardiol. 2012, 58-59. (Epub ahead of print).
64. Tremblay M.S., Shephard R.J., Brawley L.R., Cameron C., Craig C.L., Duggan M., Esliger D.W., Hearst W., Hicks A., Janssen I., Katzmarzyk P.T., Latimer A.E., Ginis K.A., McGuire A., Paterson D.H., Sharratt M., Spence J.C., Timmons B., Warburton D., Young T.K., Zehr L. Physical activity guidelines and guides for Canadians: facts and future. Can. J. Public Health 2007, 98(Suppl. 2):218-224. (Revue canadienne de sante publique).
65. Tschentscher M., Niederseer D., Niebauer J. Health benefits of Nordic walking: a systematic review. Am. J. Prev. Med. 2013, 44:76-84.
66. Tsouli S.G., Liberopoulos E.N., Mikhailidis D.P., Athyros V.G., Elisaf M.S. Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander?. Metabolism 2006, 55:1293-1301.
67. Venojärvi M., Wasenius N., Manderoos S., Heinonen O.J., Hernelahti M., Lindholm H., Surakka J., Lindström J., Aunola S., Atalay M., Eriksson J.G. Nordic walking decreased circulating chemerin and leptin concentrations in middle-aged men with impaired glucose regulation. Ann. Med. 2013, 45:162-170.
68. Villarreal-Molina M.T., Antuna-Puente B. Adiponectin: anti-inflammatory and cardioprotective effects. Biochimie 2012, 94:2143-2149.
69. Vincent H.K., Bourguignon C., Vincent K.R. Resistance training lowers exercise-induced oxidative stress and homocysteine levels in overweight and obese older adults. Obesity (Silver Spring) 2006, 14:1921-1930.
70. Wasenius N., Venojärvi M., Manderoos S., Surakka J., Lindholm H., Heinonen O.J., Eriksson J.G., Mälkiä E., Aunola S. Unfavorable influence of structured exercise program on total leisure-time physical activity. Scand. J. Med. Sci. Sports 2012, (Epub ahead of print).
71. Wendelin-Saarenhovi M., Oikonen M., Loo B.M., Juonala M., Kähönen M., Viikari J.S., Raitakari O.T. Plasma osteopontin is not associated with vascular markers of subclinical atherosclerosis in a population of young adults without symptoms of cardiovascular disease. The cardiovascular risk in young Finns study. Scand. J. Clin. Lab. Invest. 2011, 71:683-689.
72. Wycherley T.P., Brinkworth G.D., Noakes M., Buckley J.D., Clifton P.M. Effect of caloric restriction with and without exercise training on oxidative stress and endothelial function in obese subjects with type 2 diabetes. Diabetes Obes. Metab. 2008, 10:1062-1073.
73. Yilmaz Y., Ozturk O., Alahdab Y.O., Senates E., Colak Y., Doganay H.L., Coskunpinar E., Oltulu Y.M., Eren F., Atug O., Tuncer I., Imeryuz N. Serum osteopontin levels as a predictor of portal inflammation in patients with nonalcoholic fatty liver disease. Dig. Liver Dis. 2013, 45:58-62.